Cna Financial Corp Pfizer Inc Transaction History

Cna Financial Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$26.13 - $33.94 $7.84 Million - $10.2 Million	300,000 New	300,000 $8.64 Million
Q1 2022 May 10, 2022	SELL	$45.75 - $56.69 $6.86 Million - $8.5 Million	-150,000 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $2.07 Million - $3.06 Million	-50,000 Reduced 25.0%	150,000 $8.86 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $7.85 Million - $10.1 Million	200,000 New	200,000 $8.6 Million
Q1 2020 May 12, 2020	SELL	$27.03 - $38.62 $2.38 Million - $3.4 Million	-88,015 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$32.92 - $37.36 $1.08 Million - $1.22 Million	-32,755 Reduced 27.12%	88,015 $3.45 Million
Q3 2019 Nov 06, 2019	SELL	$32.49 - $42.13 $1.77 Million - $2.3 Million	-54,588 Reduced 31.13%	120,770 $4.34 Million
Q2 2019 Aug 13, 2019	BUY	$36.98 - $41.52 $1.31 Million - $1.47 Million	35,488 Added 25.37%	175,358 $7.6 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $1.79 Million - $2.04 Million	-46,621 Reduced 25.0%	139,870 $6.11 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $1.94 Million - $2.25 Million	-60,910 Reduced 24.62%	186,491 $6.62 Million
Q3 2017 Nov 07, 2017	BUY	$31.0 - $34.15 $7.67 Million - $8.45 Million	247,401	247,401 $8.83 Million

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Cna Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Cna Financial Corp with notifications on news.